171 related articles for article (PubMed ID: 35974237)
1. Evaluation of EDTA Dianhydride Versus Diphenyl Carbonate Nanosponges for Curcumin.
Mashaqbeh H; Obaidat R; Al-Shar'i NA
AAPS PharmSciTech; 2022 Aug; 23(7):229. PubMed ID: 35974237
[TBL] [Abstract][Full Text] [Related]
2. Weak complexation of 5-fluorouracil with β-cyclodextrin, carbonate, and dianhydride crosslinked β-cyclodextrin:
Mashaqbeh H; Obaidat R; Al-Shar'i NA; El-Elimat T; Alnabulsi S
Res Pharm Sci; 2022 Aug; 17(4):334-349. PubMed ID: 36034082
[TBL] [Abstract][Full Text] [Related]
3. Evaluation and Characterization of Curcumin-β-Cyclodextrin and Cyclodextrin-Based Nanosponge Inclusion Complexation.
Mashaqbeh H; Obaidat R; Al-Shar'i N
Polymers (Basel); 2021 Nov; 13(23):. PubMed ID: 34883577
[TBL] [Abstract][Full Text] [Related]
4. Solubility and dissolution rate enhancement of ibuprofen by cyclodextrin based carbonate nanosponges.
Shoaib QU; Latif S; Ijaz QA; Afzal H; Siddique MI; Hussain A; Arshad MS; Bukhari NI; Abbas N
Pak J Pharm Sci; 2021 May; 34(3(Supplementary)):1045-1055. PubMed ID: 34602431
[TBL] [Abstract][Full Text] [Related]
5. Ester-Based Hydrophilic Cyclodextrin Nanosponges for Topical Ocular Drug Delivery.
Hayiyana Z; Choonara YE; Makgotloe A; du Toit LC; Kumar P; Pillay V
Curr Pharm Des; 2016; 22(46):6988-6997. PubMed ID: 27981908
[TBL] [Abstract][Full Text] [Related]
6. Effect of inclusion complexation of meloxicam with β-cyclodextrin- and β-cyclodextrin-based nanosponges on solubility, in vitro release and stability studies.
Shende PK; Gaud RS; Bakal R; Patil D
Colloids Surf B Biointerfaces; 2015 Dec; 136():105-10. PubMed ID: 26364091
[TBL] [Abstract][Full Text] [Related]
7. Cyclodextrin based nanosponge of norfloxacin: Intestinal permeation enhancement and improved antibacterial activity.
Mendes C; Meirelles GC; Barp CG; Assreuy J; Silva MAS; Ponchel G
Carbohydr Polym; 2018 Sep; 195():586-592. PubMed ID: 29805015
[TBL] [Abstract][Full Text] [Related]
8. CDI cross-linked β-cyclodextrin nanosponges of paliperidone: synthesis and physicochemical characterization.
Sherje AP; Surve A; Shende P
J Mater Sci Mater Med; 2019 Jun; 30(6):74. PubMed ID: 31197491
[TBL] [Abstract][Full Text] [Related]
9. Pyromellitic dianhydride crosslinked cyclodextrin nanosponges for curcumin controlled release; formulation, physicochemical characterization and cytotoxicity investigations.
Rafati N; Zarrabi A; Caldera F; Trotta F; Ghias N
J Microencapsul; 2019 Dec; 36(8):715-727. PubMed ID: 31530203
[No Abstract] [Full Text] [Related]
10. Novel cyclodextrin nanosponges for delivery of calcium in hyperphosphatemia.
Shende P; Deshmukh K; Trotta F; Caldera F
Int J Pharm; 2013 Nov; 456(1):95-100. PubMed ID: 23954237
[TBL] [Abstract][Full Text] [Related]
11. Investigation of Cyclodextrin-Based Nanosponges for Solubility and Bioavailability Enhancement of Rilpivirine.
Rao MRP; Chaudhari J; Trotta F; Caldera F
AAPS PharmSciTech; 2018 Jul; 19(5):2358-2369. PubMed ID: 29869305
[TBL] [Abstract][Full Text] [Related]
12. Development of Diphenyl carbonate-Crosslinked Cyclodextrin Based Nanosponges for Oral Delivery of Baricitinib: Formulation, Characterization and Pharmacokinetic Studies.
Aldawsari MF; Alhowail AH; Anwer MK; Ahmed MM
Int J Nanomedicine; 2023; 18():2239-2251. PubMed ID: 37139486
[TBL] [Abstract][Full Text] [Related]
13. Formulation Optimization and Biopharmaceutical Evaluation of Imatinib Mesylate Loaded β-cyclodextrin Nanosponges.
Kamble M; Zaheer Z; Mokale S; Zainuddin R
Pharm Nanotechnol; 2019; 7(5):343-361. PubMed ID: 31549599
[TBL] [Abstract][Full Text] [Related]
14. Encapsulation of Babchi Oil in Cyclodextrin-Based Nanosponges: Physicochemical Characterization, Photodegradation, and In Vitro Cytotoxicity Studies.
Kumar S; ; Trotta F; Rao R
Pharmaceutics; 2018 Sep; 10(4):. PubMed ID: 30261580
[TBL] [Abstract][Full Text] [Related]
15. Formulation and evaluation of cyclodextrin-based nanosponges of griseofulvin as pediatric oral liquid dosage form for enhancing bioavailability and masking bitter taste.
Omar SM; Ibrahim F; Ismail A
Saudi Pharm J; 2020 Mar; 28(3):349-361. PubMed ID: 32194337
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo evaluation of cyclodextrin-based nanosponges for enhancing oral bioavailability of atorvastatin calcium.
Zidan MF; Ibrahim HM; Afouna MI; Ibrahim EA
Drug Dev Ind Pharm; 2018 Aug; 44(8):1243-1253. PubMed ID: 29452493
[TBL] [Abstract][Full Text] [Related]
17. Improving the solubility and in vitro cytotoxicity (anticancer activity) of ferulic acid by loading it into cyclodextrin nanosponges.
Rezaei A; Varshosaz J; Fesharaki M; Farhang A; Jafari SM
Int J Nanomedicine; 2019; 14():4589-4599. PubMed ID: 31296988
[No Abstract] [Full Text] [Related]
18. Cyclodextrin-based nanosponges encapsulating camptothecin: physicochemical characterization, stability and cytotoxicity.
Swaminathan S; Pastero L; Serpe L; Trotta F; Vavia P; Aquilano D; Trotta M; Zara G; Cavalli R
Eur J Pharm Biopharm; 2010 Feb; 74(2):193-201. PubMed ID: 19900544
[TBL] [Abstract][Full Text] [Related]
19. Design & development of nanosponge loaded topical gel of curcumin and caffeine mixture for augmented treatment of psoriasis.
Iriventi P; Gupta NV; Osmani RAM; Balamuralidhara V
Daru; 2020 Dec; 28(2):489-506. PubMed ID: 32472531
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and Characterization of Carboxymethyl Chitosan Nanosponges with Cyclodextrin Blends for Drug Solubility Improvement.
Rizvi SSB; Akhtar N; Minhas MU; Mahmood A; Khan KU
Gels; 2022 Jan; 8(1):. PubMed ID: 35049590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]